| # | Title | Journal | Year | Citations |
|---|
| 1 | Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis | Travel Medicine and Infectious Disease | 2020 | 1,781 |
| 2 | Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study | Travel Medicine and Infectious Disease | 2020 | 605 |
| 3 | Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France | Travel Medicine and Infectious Disease | 2020 | 372 |
| 4 | COVID-19 in Latin America: The implications of the first confirmed case in Brazil | Travel Medicine and Infectious Disease | 2020 | 372 |
| 5 | Meta-analysis of probiotics for the prevention of traveler's diarrhea | Travel Medicine and Infectious Disease | 2007 | 327 |
| 6 | Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis | Travel Medicine and Infectious Disease | 2020 | 325 |
| 7 | Remdesivir as a possible therapeutic option for the COVID-19 | Travel Medicine and Infectious Disease | 2020 | 250 |
| 8 | COVID-19 social distancing in the Kingdom of Saudi Arabia: Bold measures in the face of political, economic, social and religious challenges | Travel Medicine and Infectious Disease | 2020 | 237 |
| 9 | Going global – Travel and the 2019 novel coronavirus | Travel Medicine and Infectious Disease | 2020 | 234 |
| 10 | Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence | Travel Medicine and Infectious Disease | 2020 | 227 |
| 11 | Sars-Cov-2: Underestimated damage to nervous system | Travel Medicine and Infectious Disease | 2020 | 220 |
| 12 | A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease | Travel Medicine and Infectious Disease | 2020 | 220 |
| 13 | Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis | Travel Medicine and Infectious Disease | 2020 | 209 |
| 14 | Spatial transmission of COVID-19 via public and private transportation in China | Travel Medicine and Infectious Disease | 2020 | 190 |
| 15 | Cutaneous leishmaniasis treatment | Travel Medicine and Infectious Disease | 2007 | 187 |
| 16 | Salmonella infections: An update on epidemiology, management, and prevention | Travel Medicine and Infectious Disease | 2011 | 183 |
| 17 | Chikungunya and dengue autochthonous cases in Europe, 2007–2012 | Travel Medicine and Infectious Disease | 2013 | 176 |
| 18 | SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus | Travel Medicine and Infectious Disease | 2020 | 176 |
| 19 | Fatigue in aviation | Travel Medicine and Infectious Disease | 2005 | 164 |
| 20 | Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis | Travel Medicine and Infectious Disease | 2020 | 164 |
| 21 | The efficacy of repellents against Aedes, Anopheles, Culex and Ixodes spp. – A literature review | Travel Medicine and Infectious Disease | 2013 | 162 |
| 22 | Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19) | Travel Medicine and Infectious Disease | 2020 | 162 |
| 23 | Detection and analysis of nucleic acid in various biological samples of COVID-19 patients | Travel Medicine and Infectious Disease | 2020 | 158 |
| 24 | The severe acute respiratory syndrome: Impact on travel and tourism | Travel Medicine and Infectious Disease | 2006 | 157 |
| 25 | Time series modelling to forecast the confirmed and recovered cases of COVID-19 | Travel Medicine and Infectious Disease | 2020 | 155 |
| 26 | Tick-borne encephalitis: Pathogenesis and clinical implications | Travel Medicine and Infectious Disease | 2010 | 136 |
| 27 | Long-term sequelae of chikungunya virus disease: A systematic review | Travel Medicine and Infectious Disease | 2017 | 136 |
| 28 | The arboviral burden of disease caused by co-circulation and co-infection of dengue, chikungunya and Zika in the Americas | Travel Medicine and Infectious Disease | 2016 | 134 |
| 29 | Travel implications of emerging coronaviruses: SARS and MERS-CoV | Travel Medicine and Infectious Disease | 2014 | 132 |
| 30 | The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report | Travel Medicine and Infectious Disease | 2020 | 132 |
| 31 | The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? – Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI) | Travel Medicine and Infectious Disease | 2020 | 132 |
| 32 | An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies | Travel Medicine and Infectious Disease | 2020 | 131 |
| 33 | Influenza-associated central nervous system dysfunction: A literature review | Travel Medicine and Infectious Disease | 2008 | 129 |
| 34 | COVID-19 – the role of mass gatherings | Travel Medicine and Infectious Disease | 2020 | 128 |
| 35 | Leptospirosis: An emerging disease in travellers | Travel Medicine and Infectious Disease | 2010 | 121 |
| 36 | Mapping the incidence of the COVID-19 hotspot in Iran – Implications for Travellers | Travel Medicine and Infectious Disease | 2020 | 121 |
| 37 | COVID-19: Zoonotic aspects | Travel Medicine and Infectious Disease | 2020 | 120 |
| 38 | Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis | Travel Medicine and Infectious Disease | 2020 | 118 |
| 39 | Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of a novel viral lineage? | Travel Medicine and Infectious Disease | 2022 | 118 |
| 40 | Mobile phones and malaria: Modeling human and parasite travel | Travel Medicine and Infectious Disease | 2013 | 114 |
| 41 | Non-vector-borne transmission of Zika virus: A systematic review | Travel Medicine and Infectious Disease | 2016 | 113 |
| 42 | A review of the long-term protection after hepatitis A and B vaccination | Travel Medicine and Infectious Disease | 2007 | 111 |
| 43 | Cross-sectional analysis of COVID-19 vaccine intention, perceptions and hesitancy across Latin America and the Caribbean | Travel Medicine and Infectious Disease | 2021 | 110 |
| 44 | Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot | Travel Medicine and Infectious Disease | 2020 | 109 |
| 45 | Schistosomiasis in travellers and migrants | Travel Medicine and Infectious Disease | 2011 | 107 |
| 46 | Fascioliasis: A worldwide parasitic disease of importance in travel medicine | Travel Medicine and Infectious Disease | 2014 | 106 |
| 47 | COVID-19 and dengue fever: A dangerous combination for the health system in Brazil | Travel Medicine and Infectious Disease | 2020 | 104 |
| 48 | Leishmaniasis in travelers: A literature review | Travel Medicine and Infectious Disease | 2014 | 103 |
| 49 | A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) | Travel Medicine and Infectious Disease | 2019 | 103 |
| 50 | COVID-19 disparity among racial and ethnic minorities in the US: A cross sectional analysis | Travel Medicine and Infectious Disease | 2020 | 103 |
